From the January/February 2022 issue of HealthCare Business News magazine
Both companies filed for approval from the European Commission’s competition bureau last month, and the regulator had until December 21 to approve the deal or launch a deeper investigation.
The decision not to block the deal comes just a little more than a week after the agency asked customers and competitors to write up concerns on if and how the acquisition would negatively impact their own businesses.
Ad Statistics
Times Displayed: 52968
Times Visited: 4298 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Nuance says it currently serves 77% of U.S. hospitals. In any of its deals, it can use customer data to advance its voice recognition systems. Since big cloud vendors do not have unrestrained access to customers’ data for research and development, acquiring Nuance offers Microsoft a unique opportunity but is a concern to some.
One concern was that acquiring Nuance would provide Microsoft with unrestrained access to customer data in the 77% of U.S. hospitals that Nuance serves. Another suggestion was that Microsoft could force its Office suite on Nuance customers if it were to package them together.
The U.S. Justice Department and Australian Competition Commission conducted their own reviews in June and October, respectively, but the EU review was the most extensive.
Back to HCB News
